Semaglutide was selected for Medicare drug price negotiation in 2025, with a negotiated price set to take effect in 2027 but that negotiated price applies to diabetes and cardiovascular indications covered under current Medicare statute, not to obesity, which remains statutorily excluded
Compounded versions contain the same active ingredient but are prepared by compounding pharmacies rather than the brand-name manufacturer
Abstract During an investigation of the mechanisms through which the local environment controls the fate specification of adult neural stem cells, we discovered that adult astrocytes from hippocampus are capable of regulating neurogenesis by instructing the stem cells to adopt a neuronal fate
Your provider can use biomarker and genetic data to guide selection of the approach most likely to support your long-term metabolic health
Cheri Levinson, an associate professor with the university and the director of Louisvilles Eating Anxiety Treatment Laboratory (EAT Lab), surveyed about 120 people in 2024 who were seeking care for eating disorders
